Dr. Jack Kevorkian Released From Prison; Pledges To Obey Michigan's Assisted Suicide Law, Continue Advocacy for 'End Of Life' Issues.
Dr. Kevorkian videotaped Youk's death and the tape was subsequently aired on CBS's "60 Minutes." The Youk family remains a strong supporter of Dr. Kevorkian, personally and for his advocacy of patient choice and physician assistance with end of life issues.
Upon his release, Dr. Kevorkian thanked friends and supporters who stood by him during his years in prison.
"Dr. Kevorkian will follow all conditions of his parole. He pledges not to participate in any assisted end-of-life events, but he will resume his passionate advocacy for the legalization of physician-guided termination of life related to irreversible or incurable disease, pain and suffering," said Mayer Morganroth, Esq. of Southfield, Dr. Kevorkian's attorney. "Thank God Dr. Kevorkian didn't die in prison. We will celebrate his 79th birthday a few days past schedule. Dr. Kevorkian will receive treatment for his severe health issues, including chronic Hepatitis C, and adapt to his new home and life."
Morganroth added that Dr. Kevorkian will reside in Michigan, and plans to lecture, author books, compose music, and paint.
Steve Jones is producing a feature film, with his Bee Holder Productions banner that will encompass the untold story of Dr. Jack Kevorkian and his incredible life. Glenn Rigberg is Exec. Producing and Adam Mazer is writing the script. Mazer's last project was the critically acclaimed BREACH.
According to an article, "You Don't Know Jack" on EW.com posted on October 19, 2004, Jones was reported as saying that "this is a story about an extraordinary life. No matter what you think of Kevorkian, he is a genius. His story is multifaceted and riveting."
CONTACT: Jim Miller of Publicity Works, Inc., +1-248-691-4466, firstname.lastname@example.org
|Printer friendly Cite/link Email Feedback|
|Date:||Jun 5, 2007|
|Previous Article:||Kimball Genetics, Inc. Launches the Warfarin DoseAdvise(TM) Genetic Test, Ideally Suited for Clinicians to Improve Warfarin Therapy.|
|Next Article:||Webster Announces New Share Repurchase Program.|